Skip to content

Public FDA record

Z-1672-2025: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987

Recall record Z-1672-2025 for Beckman Coulter Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1672-2025
Company in FDA record
Beckman Coulter Inc.
FDA classification date
Apr 25, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The reason for the recall is incorrect sample barcode identification and processing errors that result in the reporting of erroneous and delayed results.

Source facts

Action
On 03/17/2025, the firm sent an "URGENT MEDICAL DEVICE RECALL" Letter via email and postal mail to customers informing them that it was determined that the DxC 500 AU Clinical Chemistry Analyzer might assign a test result to an incorrect sample ID under the following workflow conditions. If after loading a barcoded sample tube (Sample A) analyzes are not completed or remain "in pending", and operator attempts to analyze a second sample tube (Sample B) in the same positions, the analyzer will complete and report the pending tests associated with Sample A. No results will be reported for Sample B. Customers are instructed to: . Beckman Coulter recommends reviewing your laboratory workflow, sample labeling/label integrity and positioning to determine impact and sharing this with your laboratory and/or Medical Director. . For current software version is V1.3, V1.4, V1.4.1, or V1.4.2 customers, contact your Beckman Coulter service representative at your earliest convenience to upgrade to software V1.4.3. To check the software version, follow the instructions in the Viewing Analyzer Version Information topic in the IFU. . The latest available system software (software V1.4.3) provides improved sample event information and real time reporting, identifying the specific location of the sample with tests that are not completed. This software will help in the management of this issue. . Follow the attached appendix A Job Aid, which will prevent the operator workflow described in the ISSUE section. The Job Aid will outline how to use the sample list to manage the samples which have not completed. . There is no requirement to reverify applications, for example, precision studies. . Beckman Coulter recommends posting this Recall Letter on or near the affected systems until the corrections have been made. any questions, contact Customer Support Center: . From website: http://www.beckmancoulter.com . Troubleshooting Hotline: (800) 854-3633
Initiated
2025-03-17
Root cause
Under Investigation by firm
Distribution
Worldwide - U.S. Nationwide distribution including in the states of AL, CA, CO, GA, ID, IL, IN, LA, MA, MI,MN, MS, MT, NC, NM, NV, NY, OK, OR, PA, PR, SC, TN, TX, WA, and WI. The countries of Australia, Belgium, Bosnia and Herzegovina, Canada, Chile, Croatia, Egypt, Ethiopia, France, Georgia, Germany, Ghana, India, Italy, Korea, Lebanon, Libya, Malaysia, Netherlands, North Macedonia, Oman, Paraguay, Philippines, Poland, Puerto Rico, Qatar, Saudi Arabia, Seychelles, Slovakia, South Africa, Spain, Switzerland, and Tunisia.
Recall number
Z-1672-2025
Recall status
Open, Classified
CDRH record ID
213014
FDA classified
2025-04-25
Recall event number
96483

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗